D. O. E. Gebhardt

463 total citations
33 papers, 297 citations indexed

About

D. O. E. Gebhardt is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Obstetrics and Gynecology. According to data from OpenAlex, D. O. E. Gebhardt has authored 33 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Obstetrics and Gynecology. Recurrent topics in D. O. E. Gebhardt's work include Neonatal Respiratory Health Research (7 papers), Pregnancy and preeclampsia studies (6 papers) and Lipid metabolism and disorders (3 papers). D. O. E. Gebhardt is often cited by papers focused on Neonatal Respiratory Health Research (7 papers), Pregnancy and preeclampsia studies (6 papers) and Lipid metabolism and disorders (3 papers). D. O. E. Gebhardt collaborates with scholars based in Netherlands, Germany and France. D. O. E. Gebhardt's co-authors include P. D. Nieuwkoop, M.J. van Logten, A. J. Moolenaar, Eva H. Baart de la Faille-Kuyper, J.H. Nagel, Arnoud P. van Seters, L. C. Paul, C.M. van Gent, F.C. Reman and Jacob Faber and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Development.

In The Last Decade

D. O. E. Gebhardt

32 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. O. E. Gebhardt Netherlands	10	71	63	46	45	36	33	297
Carl G. Beling United States	12	133 1.9×	20 0.3×	96 2.1×	34 0.8×	45 1.3×	22	525
Won Jun Choi South Korea	10	28 0.4×	54 0.9×	30 0.7×	33 0.7×	28 0.8×	30	303
David T. Duong United States	7	131 1.8×	80 1.3×	64 1.4×	35 0.8×	40 1.1×	8	348
Alex Russell Israel	11	89 1.3×	23 0.4×	25 0.5×	94 2.1×	31 0.9×	24	305
F. M. Wittmaack United States	8	106 1.5×	65 1.0×	10 0.2×	113 2.5×	25 0.7×	11	377
Toshiro Tominaga Japan	12	73 1.0×	34 0.5×	36 0.8×	94 2.1×	20 0.6×	24	393
I. Downing United Kingdom	11	51 0.7×	16 0.3×	34 0.7×	49 1.1×	22 0.6×	19	385
G. Yedwab Israel	10	48 0.7×	18 0.3×	16 0.3×	83 1.8×	12 0.3×	24	315
Paul H. Guttman United States	11	48 0.7×	36 0.6×	44 1.0×	41 0.9×	9 0.3×	21	335
F. Fernandes‐Costa South Africa	15	101 1.4×	48 0.8×	12 0.3×	49 1.1×	12 0.3×	29	453

Countries citing papers authored by D. O. E. Gebhardt

Since Specialization

Citations

This map shows the geographic impact of D. O. E. Gebhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. O. E. Gebhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. O. E. Gebhardt more than expected).

Fields of papers citing papers by D. O. E. Gebhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. O. E. Gebhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. O. E. Gebhardt. The network helps show where D. O. E. Gebhardt may publish in the future.

Co-authorship network of co-authors of D. O. E. Gebhardt

This figure shows the co-authorship network connecting the top 25 collaborators of D. O. E. Gebhardt. A scholar is included among the top collaborators of D. O. E. Gebhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. O. E. Gebhardt. D. O. E. Gebhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Signetti, Stefano, et al.. (2024). Pellet Shattering Process for the Iter Disruption Mitigation System – Part II: Synthetic-Diagnostics-Based Fragment Tracking, Calibration, and Validation of Simulation Models. Fraunhofer-Publica (Fraunhofer-Gesellschaft).

Woelber, Johan Peter, D. O. E. Gebhardt, & Philippe P. Hujoel. (2023). Free sugars and gingival inflammation: A systematic review and meta‐analysis. Journal Of Clinical Periodontology. 50(9). 1188–1201. 8 indexed citations

Gebhardt, D. O. E.. (2005). Off-label administration of drugs to healthy military personnel. Dubious ethics of preventive measures. Journal of Medical Ethics. 31(5). 268–268. 2 indexed citations

Gebhardt, D. O. E.. (2003). Patient organisations should also establish databanks on medical complications. Journal of Medical Ethics. 29(2). 115–115. 3 indexed citations

Gebhardt, D. O. E.. (2003). MRSA in the Netherlands: preventive measure raises a moral issue. Journal of Medical Ethics. 29(4). 212–212. 7 indexed citations

Gebhardt, D. O. E.. (2002). Sperm donor suffers years later from inherited disease. Journal of Medical Ethics. 28(4). 213–214. 8 indexed citations

Gebhardt, D. O. E., A. J. Moolenaar, & Arnoud P. van Seters. (1993). Mitotane (o,p′-DDD) Administration Raises the Serum Level of High Density Lipoprotein (HDL) in Normotriglyceridemia. Hormone and Metabolic Research. 25(4). 240–241. 4 indexed citations

Gebhardt, D. O. E., A. J. Moolenaar, Arnoud P. van Seters, E. A. van der Velde, & J.A. Gevers Leuven. (1992). The distribution ofo,p′-DDD (Mitotane) among serum lipoproteins in normo- and hypertriglyceridemia. Cancer Chemotherapy and Pharmacology. 29(4). 331–334. 17 indexed citations

Gebhardt, D. O. E., et al.. (1985). A semi-automated and standardized method of determining the lamellar body content of amniotic fluid. European Journal of Obstetrics & Gynecology and Reproductive Biology. 19(3). 145–150. 1 indexed citations

10.

Gebhardt, D. O. E., et al.. (1985). The Fluorimetric Determination of the Lecithin/Sphingomyelin Ratio of Amniotic Fluid after HPLC. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 22(3). 321–323. 8 indexed citations

11.

Egberts, J., et al.. (1983). Fluorometric procedure for determining "lamellar body" phospholipids in the particulate fraction of amniotic fluid after filtration.. Clinical Chemistry. 29(2). 362–365. 1 indexed citations

12.

Gebhardt, D. O. E., et al.. (1983). The lipoprotein profile and phospholipase activity of subretinal fluid. Experimental Eye Research. 36(3). 381–388. 7 indexed citations

13.

Gebhardt, D. O. E.. (1983). Azathioprine teratogenicity: review of the literature and case report.. PubMed. 61(2). 270–270. 8 indexed citations

14.

Gebhardt, D. O. E., et al.. (1980). Similarity between the high density lipoprotein profile of fetal lung and of amniotic fluid. Clinica Chimica Acta. 102(2-3). 237–239. 2 indexed citations

15.

Gebhardt, D. O. E., et al.. (1980). Evidence for the existence of 2 types of α1-lipoprotein in amniotic fluid from pregnancies older than 20 weeks. Cellular and Molecular Life Sciences. 36(6). 643–644. 1 indexed citations

16.

Gebhardt, D. O. E., et al.. (1979). The lipoprotein composition of amniotic fluid. Clinica Chimica Acta. 94(1). 93–100. 16 indexed citations

17.

Gebhardt, D. O. E., et al.. (1975). A study of the lecithin/sphingomyelin ratio of amniotic fluid. Clinica Chimica Acta. 64(2). 133–142. 8 indexed citations

18.

Gebhardt, D. O. E.. (1973). RELATION BETWEEN LECITHIN/SPHINGOMYELIN RATIOS OF AMNIOTIC FLUID AND METHOD OF DETERMINATION. The Lancet. 301(7805). 726–726. 14 indexed citations

19.

Gebhardt, D. O. E.. (1969). THE EFFECTS OF STARVATION OR OF TREATMENT WITH CYTOTOXIC AGENTS ON PREGNANCY IN MICE. Reproduction. 19(3). 519–526. 11 indexed citations

20.

Gebhardt, D. O. E. & Jacob Faber. (1966). The influence of aminopterin on limb regeneration in Ambystoma mexicanum. Development. 16(1). 143–158. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact